PDCD1 and gestational trophoblastic neoplasm: NCCN clinical practice guidelines recommend PD-1/PD-L1 inhibitors (Pembrolizumab, Nivolumab and Avelumab) as an option for the treatment of GTN resistant to chemotherapy [8].